Quick Answer
Universe Pharmaceuticals INC reported R&D Expense of $671.76 million for fiscal year 2025.
Universe Pharmaceuticals INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $671.76M | -77.8% |
| 2024 | $3.03B | -37.6% |
| 2023 | $4.86B | +63457.2% |
| 2022 | $7.64M | +39.9% |
| 2021 | $5.47M | +837.3% |
| 2020 | $583.1K | -5.7% |
| 2019 | $618.4K | — |
- Universe Pharmaceuticals INC showed a decrease of -77.8% in R&D Expense compared to the prior fiscal year.
- Over the 2019–2025 period, Universe Pharmaceuticals INC’s r&d expense has grown by 108522.4% (from $618.4 thousand to $671.76 million).
- The most recent figure is from Universe Pharmaceuticals INC’s fiscal year 2025 report (Form 20-F), filed with the SEC on January 29, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: